Company Overview - Dongxiao Biotechnology Co., Ltd. announced plans to publicly issue up to 28,207,567 shares to unspecified qualified investors and list on the Beijing Stock Exchange [1] - The public shareholders will hold no less than 25% of the total share capital after the issuance [1] - The company may utilize an overallotment option, allowing for an additional issuance of up to 15% of the public offering shares [1] Fundraising Purpose - The funds raised will be allocated to projects including functional sugar alcohol industrial upgrade, high-value amino acid intelligent construction, innovation R&D base, and working capital supplementation [1] Industry Insights - The global amino acid market is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2027, reaching a production scale of 13.8 million tons by 2027 [2] - In 2023, China's share of global feed amino acid production (including lysine, methionine, threonine, and tryptophan) is projected to increase to 70.4% [2] - The Chinese plant-based cream market is estimated to reach approximately 9.008 billion yuan in 2023, with a year-on-year growth of about 9.99% [2] Financial Performance - The company reported a revenue of 7.84 billion yuan and a net profit of 578 million yuan for the year 2024, reflecting a year-on-year increase of 93.98% [2]

Core Viewpoint Several companies listed on the New Third Board have announced significant developments regarding their plans to go public on the Beijing Stock Exchange, including fundraising initiatives and entering the counseling phase for their listings. Group 1: Listing Progress - Dongxiao Biological Technology Co., Ltd. has approved a proposal to apply for public stock issuance and listing on the Beijing Stock Exchange, aiming to raise funds for projects including functional sugar alcohol industrial upgrades and high-value amino acid construction [2] - Shuoen Network Technology Co., Ltd. has entered the counseling phase for its listing application after signing a counseling agreement with Shenwan Hongyuan Securities [3] - Jinli Transmission Technology Co., Ltd. has also entered the counseling phase for its listing application, focusing on micro-motor and micro-transmission system development [4] - Zetian Chunlai Technology Co., Ltd. has begun its counseling phase for listing after submitting its application materials to the regulatory authority [5] - Huaxin Kecai Technology Co., Ltd. has entered the counseling phase for its listing application, specializing in wind measurement laser radar technology [6] - Haihong Hydraulic Technology Co., Ltd. has signed a counseling agreement for its listing application and submitted the necessary materials [7] Group 2: Major Contracts - Suizhong Technology Co., Ltd. has successfully won a bid for a digital asset management and operation system project with a central enterprise, with a total contract value of RMB 1.39 million [12] Group 3: External Investments - Hainan Shanxiang Times Education Technology Co., Ltd. plans to increase capital in its wholly-owned subsidiary, Henan Shanxiang Education Consulting Co., Ltd., introducing new investors [13] - Suzhou Feichi Environmental Technology Co., Ltd. intends to participate in the capital increase of Suzhou Ouchi Intelligent Technology Co., Ltd. [15] - Shaanxi Ruike New Materials Co., Ltd. plans to establish a wholly-owned subsidiary in Zhuhai with a registered capital of RMB 20 million [16] - Chengdu Sihan Technology Co., Ltd. aims to set up a wholly-owned subsidiary focused on technology research and product innovation in non-core business areas [17] Group 4: Financial Management - Suzhou Jinqian New Materials Co., Ltd. plans to invest up to RMB 50 million of idle funds in low-risk financial products to enhance fund utilization [18] - Zhejiang Apollo Sports Technology Co., Ltd. intends to use idle funds to purchase short-term financial products, with a maximum balance of RMB 300 million [19] - Huayou Technology Co., Ltd. plans to invest up to RMB 30 million of idle funds in short-term financial products [20] - Shanghai Songke Automation Co., Ltd. aims to use idle funds for purchasing structured deposits and financial products, with a limit of RMB 70 million [21] - Shiyan Precision New Power Technology Co., Ltd. plans to use up to RMB 80 million of idle funds for cash management through financial products [22][23] Group 5: Annual Performance - Shanghai Jinghong International Logistics Co., Ltd. reported a net profit increase of 16.90% for the year 2025, despite a slight decrease in revenue [25]

Group 1 - The event "Exploring the Trillion-Yuan Biomanufacturing Synthesis Code" aims to showcase Shandong's biomanufacturing innovations and industry advantages, enhancing brand influence and accelerating new productivity development [1][4] - Shandong is recognized as a leader in biomanufacturing in China, with the most diverse product types and significant international standing [4][11] - The biomanufacturing industry in Shandong has achieved a unique advantage characterized by scale, complete supply chains, and active innovation, with several key products holding the world's largest production capacity [8][11] Group 2 - The provincial government plans to strengthen policy support and complete the "14th Five-Year" development plan for the biomanufacturing industry by the end of the year [8] - The industry is projected to exceed a production value of 680 billion yuan in 2024, with significant contributions to green products and carbon emission reductions [11] - Leading companies in the biomanufacturing sector, such as Huaxi Biotechnology Co., Ltd. and Shandong Bailong Chuangyuan Biotechnology Co., Ltd., shared their achievements and experiences during the event [16]

Core Viewpoint - The company, Zhejiang Huakang Pharmaceutical Co., Ltd., has decided to terminate certain fundraising investment projects and permanently supplement the remaining funds into working capital, along with the cancellation of the fundraising special account [2][12]. Fundraising Basic Situation - The company raised a total of RMB 150,449.82 million from its initial public offering, with a net amount of RMB 137,477.15 million after deducting issuance costs of RMB 12,972.67 million [2][3]. Overview of Fundraising Investment Projects - The company has made several changes to its fundraising investment projects, including the termination of the "Viscose Fiber Press Liquid Comprehensive Utilization Industrialization Project" and reallocating funds to the "Annual Production of 30,000 Tons of High-Purity Crystalline Erythritol Construction Project" [3][4]. - The remaining unallocated funds of RMB 2,528.75 million were to be managed in a special fundraising account [3]. Project Termination and Adjustments - In 2024, the company decided to terminate the "Functional Sugar Alcohol Technology R&D Center Construction Project" and reallocate the remaining funds of RMB 12,963.95 million to working capital [5][8]. - The company adjusted the internal investment structure of the R&D center project, increasing construction investment by RMB 2,000.00 million and reducing equipment investment by the same amount [5][8]. Remaining Fund Usage Plan - The remaining funds after project termination will be permanently supplemented into working capital to enhance operational efficiency and maximize shareholder value [11][12]. Approval Procedures - The company has followed necessary internal approval procedures for the termination of fundraising investment projects and the reallocation of funds, ensuring compliance with relevant regulations [12][14].

Group 1 - The latest stock price of Huakang Co., Ltd. is 18.05 yuan, up 0.39% from the previous trading day, with a trading volume of 24,473 hands and a transaction amount of 44 million yuan [1] - The company has a total market capitalization of 5.47 billion yuan and a price-to-earnings ratio of 16.87 times [1] - Huakang Co., Ltd. operates in the food and beverage sector, focusing on the research and production of functional sugar alcohols, starch sugars, and health food ingredients [1] Group 2 - On August 6, the company disclosed the institutional research records from July 1, with 10 institutions including Guosen Securities and Southern Fund participating, focusing on the development of the company's sugar alcohol business [1] - This marks the 95th institutional research activity for the company in the past year [1] - On August 6, the net outflow of main funds was 3.41 million yuan, with a cumulative net outflow of 10.03 million yuan over the past five trading days [1]

Market Overview - In June 2025, the stock market experienced an overall rise due to the easing of Middle Eastern tensions and multiple thematic catalysts, while bond market interest rates declined [4][7] - The average parity of convertible bonds reached a near-high level, with significant valuation increases for bond-like convertible bonds [5][7] - The China Securities Convertible Bond Index closed at 442.1 points on June 27, marking a 2.68% increase for the month [7] Convertible Bond Market Analysis - As of June 27, the arithmetic average parity of convertible bonds was 103.14 yuan, up 3.77% from the previous month, placing it in the 98th percentile since 2023 [7][23] - The average conversion premium rate for bonds in the price range of 90 to 125 yuan was 21.13%, also in the 48th percentile for 2023 [7][23] - The average yield to maturity (YTM) for bond-like convertible bonds fell below zero, indicating a shift in market sentiment [7][29] Recommended Convertible Bonds - The "Top Ten Convertible Bonds" for July 2025 include: - **Shenzhen Gas Convertible Bond (113067.SH)**: High balance and stable profitability, rated AAA [31][32] - **Hongcheng Convertible Bond (110077.SH)**: Stable operations and high dividend payout, rated AA+ [31][43] - **Weir Convertible Bond (113616.SH)**: Strong growth in consumer electronics and automotive sectors, rated AA+ [31][55] - **Jingce Convertible Bond (123176.SZ)**: Urgent need for domestic semiconductor testing equipment, rated AA- [31][66] - **Haoyuan Convertible Bond (118051.SH)**: Recovery trend in innovative drug development, rated AA- [31][79] - **Huakang Convertible Bond (111018.SH)**: Leading position in functional sugar alcohols, rated AA- [31][90] - **Bohai Convertible Bond (113069.SH)**: Steady growth in special alloy materials, rated AA [31][101] - **Dongcai Convertible Bond (113064.SH)**: Increased demand for high-frequency resin materials driven by AI server construction, rated AA [31][113] Industry Insights - The gas industry, represented by Shenzhen Gas, is experiencing steady growth in natural gas sales, with a 5.06% year-on-year increase in supply volume [36] - The environmental governance sector, led by Hongcheng Environment, shows stable revenue growth from water supply and treatment services, with a focus on expanding its business footprint [46] - The semiconductor industry, highlighted by Weir Group, is benefiting from increased demand in automotive electronics and consumer electronics, with significant revenue growth projected [58] - The healthcare sector, represented by Haoyuan Pharmaceutical, is positioned to capitalize on the recovery of innovative drug research and development [82]